Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer
Clinical trial NCT06843954 · COMPLETED
Trial details
- NCT number
- NCT06843954
- Sponsor
- Mohammed Mahmood Mohammed
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-11-30
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.